RecruitingNCT06278779
Esketamine or racemic ketamine for treatment-resistant depression
About this title
Read the official source — NCT06278779Medication studyAges 18+Australia
Understand this study
Who could participate?
Listed age limits: from 18 years.
What will I do during this study?
If you take part, you will be randomly assigned to receive either esketamine as a nasal spray or racemic ketamine by injection. You will receive treatment and follow-up through your clinic and answer questionnaires about mood, side effects, quality of life and daily functioning.
- Listed locations
- Camperdown and 6 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 3, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 162
- Sponsor
- The George Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Australia
- Age range
- Over 18 Years
- Official registry ID
- NCT06278779
- Official title
Show the full official title
Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-Resistant Depression: a Randomised, Rater-blinded Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Camperdown · Randwick · St Leonards
4 more locations
- Warners Bay
- Southport
- Melbourne
- Parkville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The George Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Esketamine group and Racemic ketamine.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
